Literature DB >> 30765943

Minimal/Covert Hepatic Encephalopathy - Impact of Comorbid Conditions.

Karin Weissenborn1.   

Abstract

Mild cognitive dysfunction as in minimal or covert hepatic encephalopathy (HE) can be found in a variety of metabolic disturbances, several neurological diseases, and even older age. Because liver cirrhosis usually is accompanied by one or the other of these, a differentiation between HE and cognitive decline because of comorbidities is difficult. Somehow discriminating is the impairment of motor speed and accuracy, which is more prominent in HE than in any of the comorbidities. The observation that, for example, diabetes mellitus, renal dysfunction, infections, or hyponatremia as well as older age increase the risk of developing HE indicates the interaction between these factors and liver dysfunction in the development of HE and the necessity to adjust the therapy accordingly.

Entities:  

Keywords:  DM, diabetes mellitus; HCV, hepatitis C virus; HE, hepatic encephalopathy; NCT B, number connection test B; diabetes mellitus; hyponatremia; minimal hepatic encephalopathy; renal dysfunction; septic encephalopathy

Year:  2018        PMID: 30765943      PMCID: PMC6363959          DOI: 10.1016/j.jceh.2018.08.010

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  8 in total

Review 1.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Authors:  Jeremy Louissaint; Sasha Deutsch-Link; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

Review 2.  Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?

Authors:  Simon Johannes Gairing; Eva Maria Schleicher; Christian Labenz
Journal:  Metab Brain Dis       Date:  2022-08-24       Impact factor: 3.655

Review 3.  Management of Hepatic Encephalopathy Associated with Advanced Liver Disease.

Authors:  Rita García-Martínez; Raquel Diaz-Ruiz; Marta Poncela
Journal:  Clin Drug Investig       Date:  2022-05-10       Impact factor: 3.580

Review 4.  Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives.

Authors:  Kristoffer Kjærgaard; Anne Catrine Daugaard Mikkelsen; Charlotte Wilhelmina Wernberg; Lea Ladegaard Grønkjær; Peter Lykke Eriksen; Malene Flensborg Damholdt; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Mette Munk Lauridsen; Karen Louise Thomsen
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

5.  Cognitive Impairment and Physical Frailty in Patients With Cirrhosis.

Authors:  Kacey Berry; Andres Duarte-Rojo; Joshua D Grab; Michael A Dunn; Brian J Boyarsky; Elizabeth C Verna; Matthew R Kappus; Michael L Volk; Mara McAdams-DeMarco; Dorry L Segev; Daniel R Ganger; Daniela P Ladner; Amy Shui; Monica A Tincopa; Robert S Rahimi; Jennifer C Lai
Journal:  Hepatol Commun       Date:  2021-08-24

6.  The Prevalence and Association of Cognitive Impairment with Sleep Disturbances in Patients with Chronic Liver Disease.

Authors:  Oana-Mihaela Plotogea; Camelia Cristina Diaconu; Gina Gheorghe; Madalina Stan-Ilie; Mircea-Alexandru Badea; Cristina Cijevschi Prelipcean; Gabriel Constantinescu
Journal:  Brain Sci       Date:  2022-03-26

7.  Morbidity and mortality of infections in the cirrhotic patients: a US population-based study.

Authors:  Saad Saleem; Rathnavali Katragadda; Simcha Weissman; Wissam Bleibel
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

8.  Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.

Authors:  Charlotte W Wernberg; Ove B Schaffalitzky de Muckadell; Hendrik Vilstrup; Mette M Lauridsen
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.